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Canada spends more than Italy on health per capita and as a share of GDP and has a higher 
per capita GDP.  Yet, life expectancy and infant mortality in Italy are better and have 
improved more over time.  The implication is that the Italian health care system provides 
better value for money. We examine whether Italy does get better health outcomes at lower 
costs. Using regression analysis, we find that health spending is determined by similar 
drivers in both Canada and Italy. We also find that more social spending and health 
spending in either country do not satisfactorily explain the differences in health outcomes, 
suggesting the importance of broader socio-economic determinants like income and life-
style choices.  We conclude that while the levels of per capita health spending in Canada 
are higher than Italy, this partly reflects historical inertia in Canadian health spending 
partially attributable to the higher costs of health professionals relative to Italy. 
Keywords: health, expenditures,outcomes 
JEL classifications:I1, I3, F0, H1, N3 
1     Introduction 
Canada and Italy are G7 countries with publicly funded universal health care systems that 
provide high quality health care.  International rankings usually place Canada and Italy highly 
on health care performance.  However, these rankings also often place Italy ahead in terms of 
health outcomes, even though when measured as a percentage of GDP and per capita 
expenditures Canada devotes more resources to health.  For example, the WHO 20101 rankings 
placed Italy second and Canada 30th in terms of health system performance, while a more recent 
study in the Lancet 20182 placed Italy ninth and Canada fourteenth.  Meanwhile, in terms of 
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spending as a share of GDP, a recent report placed Canada third and Italy twenty fourth.3 
Recent research shows that more health spending does not always result in improved 
outcomes4 and that “Expensive health care is not always the best health care.”5 The literature 
suggests that other social determinants also influence health outcomes.   For example, 
Rowlingson (2011), Subramanian and Kawachi (2004) and Lynch et al., (2001), draw the link 
between income inequality and mortality rates as well as health and social problems. Dutton et 
al., (2018) for Canada emphasize social spending at the provincial government level as a 
determinant of improved performance when it comes to life expectancy. 
 We compare health spending, health system parameters and outcomes in Canada and Italy 
to answer why Italy spends less on health care and yet has generally obtained better long-term 
outcomes as measured by life expectancy and infant mortality.  This disparity in long-term 
outcomes is apart from the early differential performance of the two countries with respect to 
the impact of the Covid-19 pandemic which cannot be properly addressed until a longer-term 
perspective becomes available.6 
The difference in long-term outcomes and performance may be rooted in the structure of 
the health and social expenditure network and support system in the two countries.   Notably, 
Italy devotes much more to redistributive schemes compared to Canada, and this difference 
might explain its better long-term health outcomes. We also consider differences in basic health 
care inputs and institutions that may account for the disparity in health outcomes in the two 
countries.   The efficacy and efficiency of the healthcare system is a pressing question in all 
advanced countries as they face the public health shocks from events such as the Covid-19 
pandemic and aging populations that will put pressure on future government budgets. We also 
find that while Canada does spend more but get less given its level of spending,  the health 
dollars spent at the margin seem to have yielded the same benefits in terms of life expectancy 
increases and infant mortality declines in both countries.  
The paper is divided as follows. First, we review the health care literature with respect to 
value for money in health care spending to provide context.   Second, we overview the size, 
 
3 Barua, B., S. Hasan and I. Timmermans (2017) Comparing Performance of Universal Health Care 
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of July, total Italian deaths per one million population since the start of the pandemic exceed Canada’s 
total but on a current weekly basis, Italian deaths are now below Canadian. 








structure and financing of the two health care systems and compare aggregate health care 
spending in Canada and Italy, health care resource inputs, health care status indicators and 
outcomes, and social spending and income inequality.  We then carry out a regression analysis 
to assess the determinants of health expenditures and use it to present a spending counterfactual 
simulation.  We also estimate the determinants of health outcomes – namely, life expectancy at 
birth and infant mortality. The paper concludes with a discussion as to what factors help explain 
the differences in expenditures and health outcomes between Canada and Italy.   
2    Value for Money in Health Care: A Brief Review of the Literature  
2.1    Health Spending and Health Outcomes 
In a world of unlimited wants and scarce resources, efficiency, or getting value for money, is 
paramount.  Getting the most out of inputs, such as diagnostic machinery, the number of 
doctors, and hospital beds, can translate in  extending the length and quality of life.  
Input costs can be measured in monetary terms, such as the per capita spending on health 
care, or in physical terms, such as the number of hospital beds and technical equipment.7  
Outcomes can be quantitative (lives saved or years of life gained), or qualitative (quality of 
additional years of life). A standard approach to efficiency in health economics is cost-
effectiveness analysis – that is a comparison of costs or expenditures per unit of health 
outcome.8  Health outcomes can be measured in terms of key indicators such as life expectancy 
at birth, mortality rates, or what are sometimes referred to as Quality Adjusted Life Years.9 
Measures of health system cost-effectiveness and value for money could include health costs 
per quality adjusted life year, or measures of health spending per additional year of life 
expectancy or mortality rate reduction.10 
 
7 There are also recent studies of health care system input costs at the international level and particularly 
the EU.  See Joumard, André and Nicq (2010), Asandului, Roman and Fatulescu (2014), and Medeiros 
and Schwierz (2015). 
8 See Folland, Goodman and Stano (2017: 81-107). 
9 A quality adjusted life year is a valuation of a year of life that assigns values between 0 and 1 to represent 
quality of life in each year. As another example, the Canadian Institute for Health Information (CIHI) 
(2014) suggests another approach to measure a health care system: the reduction in potential years of 
life lost (PYLL) from treatable causes of death. According to their results, the reduction in PYLL in 
Canada from treatable causes of death could be anywhere between 18 and 35 percent, depending on the 
province, which translates to preventing between 12,600 and 24,500 premature deaths CIHI (2014: 2). 
In a separate study, the CIHI found that the PYLL for Italy for the year 2010 was lower than it was for 
Canada suggesting a more cost effective or efficient health care system given the greater per capita 
health spending in Canada CIHI (2016). 
10 For a discussion of measurement of cost-effective and value for money, see Artiste and Di Matteo 
(2017). 







The connection between expenditure on health and outcomes is not necessarily monotonic. 
Indeed, the research on the relationship between health spending and health outcomes often 
shows an ambiguous relationship.  Some OECD countries, such as Spain, have high life 
expectancy, but with spending on health care in the middle of the pack.  Belgium and Denmark 
rank high in spending but have only average health outcomes. Thus, we find in general a non-
linear relationship between health spending and outcomes, at least among European OECD 
member countries11.   
Babazono and Hillman (1994) analyzed 1988 data for OECD countries, including Italy, and 
show that total health care spending and outpatient and inpatient utilization rates of the health 
care system are not related to health outcomes.  On the other hand, Anderson et. al (2000) look 
at health spending and outcomes for OECD countries for the 1960-1998 period and find a 
positive relationship between health care expenditures and health outcomes, particularly so with 
regards to the U.S.A.  
Golinelli et al., (2018) found mortality rates in Italy between 2011-14 increased because of 
government spending restraint, compared to the 1995 to 2010 period, implying that health 
expenditures do impact outcomes. However, citing Stuckler et. al (2010), they note that health 
spending cannot be considered the only determinant of mortality rates. In fact, Vercelli et. al. 
(2014) find mortality rates in Italy declining at a steady rate from the beginning of the 20th 
century, right up to 2008, while national income growth was more variable.    
Anderson and Frogner (2008) also find a tenuous relationship between health expenditures 
and health outcomes. They note that the U.S. had one of the highest per capita spending levels 
on health care in the world, yet it was equally likely to be at either the top or bottom of sixteen 
quality measures complied by the OECD. 
Other studies have also found a relatively small impact of health care spending.  Among 
these are Filmer and Pritchett (1999), and Nolte and McKee (2004). As well, Nixon and Ulman 
(2006) emphasize the complexity of associating health expenditures with outcomes, and found 
that for 15 European nations, including Italy, between 1980 and 1995, increases in health care 
spending improved infant mortality, but only a marginal impact on life expectancy. 
Cremieux et. al. (1999) analyzed Canadian provincial data for the period 1978-1992 and 
found less spending on health care in Canada lead to an increase in infant mortality and life 
expectancy (LE).   Namely, a 10% reduction in health care spending increased infant mortality 
by 0.5% and decreased LE by 6 months for men and 3 months for women.  Cremieux et. al. 
(2005a, b) focused on the impact of spending on pharmaceuticals in Canada on health outcomes 
and found a strong positive relationship on the LE and infant mortality.  On the other hand, 
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Guindon and Contoyannis (2012) found no impact on health outcomes with increased spending 
on pharmaceuticals.   
Joumard et.al. (2010) take a more comprehensive input-output approach in comparing 
OECD countries relative efficiency. They find both the Canadian and Italian system to be quite 
efficient, but the Italian health care systems has a lower mortality rate.  On an efficiency basis, 
Medeiros and Schwierz (2015) find that the Italian health care system is one of the top 
performers in terms of the amount spent on health care and outcomes, placing second on its 
constructed efficiency scale, just behind France, which spends more on health care. Thus, Italy 
is not far from the “efficiency frontier,” according to their analysis. 
2.2    Social Spending, Income Inequality and Health Outcomes 
Health outcomes stem from a production function process in which health care or health 
spending is only one input, along with  with additional socio-economic determinants.12 The  
broader determinants of health approach can include the role of schooling, spending on social 
programs and income inequality.  Social spending is a large category that in the broadest sense 
is ultimately about income redistribution. It may include welfare payments due to various 
physical or mental challenges, employment insurance programs, affordable housing programs, 
tax breaks for social purposes or low-income families, and direct in-kind provisions of goods 
and services targeting disadvantaged groups.  
Some research shows social spending has important health effects on a population.   On the 
topic of the role of social spending on infant mortality and birth outcomes, Kim and Saada 
(2013) find that income inequality and social policies, such as maternal leave policies may help 
to explain the cross-country variations in these important issues. 
Dutton et al., (2018) examine the association between health care spending, social programs 
and health outcomes in Canada using the ratio of social to health spending dollars. Using 
provincial data from 1981 to 2011 they find a 1-cent increase in social spending per dollar spent 
on health was associated with a 0.1% (95% confidence interval [CI] 0.04% to 0.16%) decrease 
in potentially avoidable mortality and a 0.01% (95% CI 0.01% to 0.02%) increase in life 
expectancy.  However, this study used only provincial social spending excluding municipal and 
federal social spending and noted that the ratio of social spending to health spending across 
Canadian provinces was low. 
Bradley and Taylor (2013) found social spending in OECD countries improves health 
outcomes.  They point out the stark example of the health care system in the U.S., one of the 
most expensive in the world, which ranks poorly on health outcomes. On a per capita basis, the 
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U.S. spends double the OECD average on health, but the outcomes are among the worst in the 
OECD. Their research show that social service spending in the U.S. was predictive of three key 
health outcomes: life expectancy, infant mortality, and maternal mortality.  
Rubin et. al. (2016) make a similar point and show that old-age spending makes a significant 
contribution to better health outcomes. They suggest that social spending and protection may 
be more important to better health outcomes in societies in which income inequality is high. 
For the U.S., they find that unemployment and income maintenance are strongly correlated with 
better health outcomes across U.S. states, but social expenditures take time to translate into 
better health outcome. 
Bradley et. al. (2011) using a pooled cross section of OECD countries in 2009 find that 
health expenditures were significantly associated with better health outcomes in only two of 
five health indicators (life expectancy and maternal mortality) while social services 
expenditures adjusted for GDP were significantly associated with better health outcomes in 
three of five indicators. The ratio of social expenditures to health expenditures was significantly 
associated with better outcomes in infant mortality, life expectancy and increased potential life 
years lost, after adjusting for the level of health expenditures and GDP.  
Lynch et. al (2004) in a review of 98 aggregate multilevel studies found income inequality 
is not associated with health outcome differences in affluent countries. Despite the tenuous 
relation between income inequality and health outcomes, they do claim that reducing income 
inequality of the most disadvantaged populations will improve their health and thus the health 
of general population.   Latif (2015) examined the effect of income inequality on health 
outcomes in Canada and found no significant impact, but that absolute household income in 
Canada had a significant positive impact on health status.   
Wilkinson and Pickett (2015) in a literature review of epidemiological causal literature find 
support for the proposition that that income inequality affects population health and wellbeing.  
Wilkinson and Pickett (2011) made similar claims in their previous work. Snowden (2011) in 
a direct response to the Wilson and Pickett position on income and inequality and population 
health dissents and argues that health outcomes are the product of diverse influences that over 
time can impact life expectancy and other health indicators.   
This paper contributes to the current literature by having a closer look at two of the G7 
countries that devote different amounts to health spending, and with different social 
expenditures and lifestyle factors to determine the contributions to health outcomes. We want 
to gain insights on whether Canada or Italy is getting greater relative value for money. 
 








3   Health System Overview: A Comparison of Health Expenditure, Indicators 
and Outcomes, and System Trends 
3.1    Canada’s Health System 
In Canada, federal and provincial governments finance public health spending but under the 
Canadian constitution the provincial governments deliver publicly funded health care to 
citizens, making for a decentralized health system with some variation in both expenditure 
levels and service provision as well as some reliance on market mechanisms for services.13 
Indeed, the OECD puts Canada into Group 2 countries along with Belgium, Australia and 
France - countries with public insurance for basic coverage and private insurance beyond the 
basic coverage.14 
 Canadian public health care is not one public health care system, but is 14 publicly funded 
systems, given that there are ten provinces and three territories along with a federal government 
with its own health obligations for indigenous peoples, the military and the RCMP.  Provincial 
and territorial government health expenditures are for insured health services and extended 
health care and are financed by own source revenues as well as federal government transfers to 
the provinces.  
Canada’s public health care system evolved in stages, starting with individual provincial 
initiatives that were followed by federal financing.  In 1957, the federal Hospital Insurance and 
Diagnostics Act established cost-sharing for provincial hospital insurance plans while the 1966 
federal Medical Care Insurance Act provides cost sharing for physician services also. Thus, 
health system financing in Canada involves several layers: 1) public services for medically 
necessary hospital, diagnostic and physician services, 2) a mix of public-private insurance 
covered services including drugs and home care and 3) entirely private services such as dental 
services and physiotherapy.15 
Canadian health care is approximately 30 percent privately and 70 percent publicly funded, 
but the proportion varies across provinces, as well as within expenditure categories.16 Private 
sector health care expenditures include those from health insurance firms, out-of-pocket 
expenditures of individuals, and patient service revenue paid by private insurers for items such 
as preferences for private hospital rooms or charges for services not deemed medically 
necessary.  It also should be noted that in Canada public finance differs from public provision.   
 
13 Marchildon (2019). 
14 OECD 2010, “Health care systems: Getting more value for money”, OECD Economics Department 
Policy Notes, No.2. 
15 Martin et al. (2018) 
16 See: Canadian Institute for Health Information. National Health Expenditure Trends 2018, 1975 to 
2017. 







Canadian physician expenditures are nearly entirely publicly financed with physicians behaving 
mainly as private independent contractors rather than salaried employees.17  Physicians in 
Canada have substantial autonomy and flexibility in their daily practices and access to physician 
services can sometimes be problematic with reliance on hospital emergency wards or walk-in 
clinics.18 
Federal transfers for provincial-territorial government health spending are made under the 
1984 Canada Health Act, which specifies the criteria under which provinces and territories get 
federal health transfers. Provincial health systems must be publicly administered, 
comprehensive in their coverage of insured services, universal in their coverage, must have 
portable benefits, and must provide reasonable access to insured services.  There is some 
variation across provincial systems in terms of what medical services and drugs are covered by 
provincial plans, but health outcomes are remarkably uniform across provinces.19 
In 2018-2019, the total value of the Canada Health Transfer to the provincial and territorial 
governments according to the Federal Department of Finance is expected to be $CAD 38.584 
billion dollars and is expected to increase to $CAD 40.373 billion by 2019-2020.20 These 
federal transfers provide about 20 to 25 percent of provincial government health expenditures, 
though the growth rate of these transfers changed after 2017 as a  new transfer formula took 
effect.   The growth rate of the Canada Health Transfer is now based on the growth rate of real 
GDP, subject to a 3 percent floor as opposed to the previous Health Accord escalator, which 
saw annual 6 percent increases.21 
3.2    Italy’s Health system 
The OECD groups the Italian health care system in Group 6, along with those of Hungary, 
Ireland, New Zealand, Norway, Poland and the U.K - health care services provided by a heavily 
regulated public centralized system, with budgetary spending limits. 22 Italy’s publicly funded 
health care system (Servizio Sanitario Nazionale-SSN) was established in 1978 and modelled 
on Britain’s National Health Service.  It is a single payer system providing universal coverage 
for all Italians, with responsibility for the organization and delivery of health services residing 
with the 19 regions and two autonomous provinces.  
 
17 For a discussion see Di Matteo (2014). 
18 See Di Matteo (2014) and Clarke (2016).  
19 See Marchildon (2019) for further discussion. 
20 See: Department of Finance Canada. https://www.fin.gc.ca/fedprov/mtp-eng.asp 
21 Norris (2018). 
22 OECD 2010, “Health care systems: Getting more value for money”, OECD Economics Department 
Policy Notes, No. 2. Canada in in Group 2, which also includes Australia, Belgium and France.  








The central government in Rome controls the tax-financed health budget, which defines the 
benefits that must be guaranteed to Italians and foreign residents. The regions are responsible 
for the organization, planning and the actual delivery of health services, through the local health 
authorities, Azienda Sanitaria Locale (ASL). The regions and the two autonomous provinces 
have substantial autonomy in how they structure their health care systems within the parameters 
established by the central government, including health care spending and delivery. However, 
it is the central government that allocates the bulk of the funds for healthcare, making it more 
centralized than the Canadian system.  Still, regions can raise additional resources, making for 
some significant regional differences in per-capita health care spending (Cicchetti and 
Gasbarrini, 2016).   
The SSN focuses on primary health care. All citizens register with a general practitioner, 
who is given strong financial incentive to keep costs low by prescribing pharmaceuticals and 
refer patients to medical specialists only as appropriate. All citizens have access to primary care 
24 hours a day, 7 days a week through not only their primary physician, but also out-of-hours 
service walk-in clinics (guarda medica). In recent years, general practitioners have been given 
financial incentives to form group medical practices, following a multi-professional and multi-
disciplinary approach.   
Since 2016, in an effort to improve efficiency through economies of scale, several regions 
have merged local health authorities into larger entities. Despite the central government’s 
commitment to a national standard of health care to all Italian citizens, there are concerns over 
regional differences in population health status and equal accessibility to quality health 
services.23   Generally, northern and central regions have higher capacity, more advanced 
diagnostic machinery, and better patient perceived quality of health care compared to southern 
Italy. Thus, it is not surprising that a significant number of patients from southern Italy travel 
to northern regions to obtain care. According to the Ministry of Health, at least 30,000 patients 
a year from the regions of Campania, Calabria, and Sicily travel north seeking better health 
care.24  
Health care in Italy is primarily publicly funded with 24 percent of expenditures privately 
funded25. While the publicly funded health care share is higher than Canada, it is lower than 
France and England, where fully 93 and 90 percent of all health spending is publicly funded. 
Private health insurance plays a minor role in Italy, accounting for only about one percent of 
total health spending in 2014. 
 
23 OECD, 2017 
24 Ibid. To the extent that three-quarter of expenditures are public, we can say that the Canadian and 
Italian health care systems are similar. 
25 OECD, 2015. 







Total health care spending declined after the 2008 global financial crisis, and remained 
essentially flat for the following 5 years, but started rising again in 2014. Containing the cost 
of health care spending has been a main concern for Italy given its relatively high public debt 
to GDP ratio. In 2016, the central government embarked on a deficit reduction plan for hospitals 
in an effort to balance their accounts. In fact, the number of acute care hospital beds has dropped 
significantly since 2000 in response to national targets to reduce all bed numbers. As is the case 
in many OECD countries, the Italian government is looking for efficiency gains from its 
national health care system. 
3.3    Health Expenditure Comparison 
Data for comparing spending indicators and outcomes across Canada and Italy come from 
OECD Health Statistics.26 Figure 1 and Table 1 compare  several health expenditure variables, 
Table 2 presents a comparison of health system resources, while Table 3 and Figures 2 and 3 
look at key health and social outcomes.   
Figure 1: Per Capita Public Health Spending, US PPP$, Canada and Italy  
 
Source: OECD Health Statistics, 2019 
 
26 Assorted years, 2018 and 2019.  http://www.oecd.org/els/health-systems/health-data.htm 








Table 1: Health Expenditure Summary Statistics: Canada, Italy, and OECD Averages 
 
 
There has been substantial growth in health spending over time in both Canada and Italy.  
However, as Figure 1 illustrates, Italian public sector health spending has more closely tracked 
the average for OECD countries, and stopped rising after the 2008-09 financial crisis.  Canada 
spends more than Italy with respect to health whether we consider total spending, public 
spending, or health as a share of GDP.  From the summaries in Table 1, over the period 2010 
to 2018, Canada spent on average 32 percent more than Italy on per capita public sector health 
spending27 and 41 percent more with respect to total per capita health spending.  As a share of 
GDP, total health spending in Canada in the 1990s, averaged 8.7 percent while it was 7.1 
percent in Italy. In the 2010s it was 10.5 percent in Canada and 8.9 percent in Italy.   
Table 2 presents average indicators by decade dealing with the deployment of resources in 
the Canadian and Italian health systems with OECD figures for comparison. Since the 1980s, 
physician density in Canada has fallen substantially below the OECD average, and since 2000 
well below the Italian figures.  While Canada began to increase physician supply after 2000, by 
the 2010s Canada was still below both the Italian and OECD averages at 2.5 physicians per 
1,000 population, while Italy was at 3.9, and the OECD average at 3.3.  
 
27 Defined as government and compulsory health insurance spending. 
1990 to 1999 2000 to 2009 2010 to 2018
Canada 1422 2251 3172
Italy 1128 1907 2408
OECD 1048 1749 2630
Canada 1985 3220 4505
Italy 1505 2495 3186
OECD 1463 2408 3508
Canada 8.7 9.2 10.5
Italy 7.1 8.2 8.9
OECD 7.1 7.9 8.8
Government and compulsory health insurance schemes, per 
capita expenditure, US$PPP
Current expenditure on health, per capita, US$PPP
Current expenditure on health, % of gross domestic product







Table 2: Health System Resources: Canada, Italy and OECD Averages 
 
While the Italian health system is more physician intensive than the Canadian one, the reverse 
is the case for nursing resources.  While nurses per 1000 population has grown over time in 
both Canada and Italy, by the 2010s, there were on average nearly twice as many nurses per 
1000 population in Canada compared to Italy. Nurses in Canada may be a partial substitute for 
both physicians and hospital beds, given that the number of total hospital beds per 1000 in 
Canada is below the Italian level.    
1990 to 1999 2000 to 2009 2010 to 2018
Canada 2.1 2.1 2.5
Italy 3.7 3.9
OECD 2.6 3 3.3
Canada 7.9 8.7 9.6
Italy 4.9 5.4
OECD 6.6 7.6 8.6
Canada 5 3.3 2.7
Italy 6.3 4.1 3.3
OECD 6.5 5.5 4.8
Canada 1.1 5.4 9.2
Italy 5.4 14.6 26
OECD 3.5 8.1 14.5
Canada 7.6 11.6 14.9
Italy 17.3 26.9 33.3
OECD 14.3 17 24.1
Canada 6.6 7 6.9
Italy 6.5 6.1 6.8
OECD 6 6 7
Total hospital beds, Per 1 000 population
Physicians, Density per 1 000 population (head counts)
Nurses, Density per 1 000 population (head counts)
MRI units, total, Per million population
CT scanners, total, Per million population
Doctors consultations, Number per capita








Medical diagnostic technology (MRI and CT scanners) has grown since the 1990s in Canada 
and Italy, but Italy has more units per capita of both technologies relative to not only Canada, 
but also the OECD.  Again, Canada may be substituting intensity of labour utilization for capital 
when it comes to diagnostics relative to Italy because the evidence available in Table 2 shows 
slightly more physician consultations per capita on average in Canada over time, despite lower 
stocks of diagnostic equipment  and fewer physicians per capita. 
3.5     Health and Social Outcome Indicators Comparison 
Table 3 summarizes some key basic health indicators of both health outcomes as well as 
potential correlates of some of those outcomes:  infant mortality rates, life expectancy at birth 
(both sexes), suicide rates, tobacco and alcohol consumption and self-reported obesity rates.  
Figures 2 and 3 provide evidence on long term social outcomes as captured by social spending 
and inequality.  
Both Canada and Italy have seen improvements in these basic health outcomes over time. 
Between 1960 and 2017, average infant mortality rates by decade in Canada declined by 81 
percent from the 1960s to the 2010s.  Italy’s reduction was steeper, falling 92 percent.  While 
annual data show that infant mortality in Italy fell below the OECD average in 1979 and has 
remained below it, infant mortality in Canada went above the OECD average for the first time 
in 2007, and has since remained above.   Between the 1960s and the 2010s, average annual life 
expectancy at birth in Canada rose from 71.7 to 81.7 years, while in Italy it rose from 69.8 to 
82.7 years.  Of additional interest, suicide rates (intentional self-harm) in both Canada and Italy 
are below the OECD average, and both have declined since the mid-1980s with suicide rates in 
Italy dramatically lower than in Canada.  
Tobacco consumption in Italy and Canada, like much of the OECD, has fallen steeply since 
the 1960s, but Italian consumption remains above both Canada and the OECD average. Alcohol 
consumption in Italy is now below the OECD average and below Canadian rates, with Italian 
decline starting in the mid-1970s.  Both of these variables can be considered important lifestyle 
inputs into health outcomes.  Finally, it should be noted that while self- reported obesity rates 
have been on the rise in both Canada and the OECD, they are lower in Italy. 
Another comparison area is social spending and income distribution given their potential 
effect on health outcomes as noted in the broader social determinants of health literature.28  Italy 
has gradually surpassed Canada when it comes to basic health indicators such as longevity and 
infant mortality and one possibility is that Italy has  achieved this because of greater social 
spending, or perhaps a more equitable distribution of income.    
 
28  Social spending and inequality may affect health stresses associated with differential positions in social 
hierarchies and status.  See: Hurley (2010: 176-178). See also see Braveman, Egerter and Williams 
(2010). 







Table 3: Health Outcome Indicators: Canada, Italy & OECD Averages  
 
Source: OECD Health Statistics (2017, 2018, 2019) 
Both Canada and Italy have seen improvements in these basic health outcomes over time. 
Between 1960 and 2017, average infant mortality rates by decade in Canada declined by 81 
percent from the 1960s to the 2010s.  Italy’s reduction was steeper, falling 92 percent.  While 
annual data show that infant mortality in Italy fell below the OECD average in 1979 and has 
remained below it, infant mortality in Canada went above the OECD average for the first time 
 
1960-1969 1970-1979 1980-1989 1990-1999 2000-2009 2010-2017
Canada 24.2 14.7 8.3 6 5.2 4.7
Italy 37 22.6 11.4 6.5 3.6 2.9
OECD 30.2 20.1 12.4 8.4 5.6 3.9
Canada 71.7 74 76.2 78 79.9 81.7
Italy 69.8 73.1 75.4 78.2 80.9 82.7
OECD 69.5 71.2 73.6 75.6 78 80.2
Canada 11 14.6 14.6 13 11.2 11.2
Italy 6.5 6.7 8.1 7.6 6.1 6.1
OECD 14.4 15.2 17.6 17 14.7 12.6
Canada 41.9 38.1 30.8 25.6 18.4 14.3
Italy 32.1 25.7 23.3 21
OECD 45.5 43.8 34.4 28.4 23.4 17.3
Canada 7.8 10.4 9.9 7.6 8 8.2
Italy 18.9 18.43 13.5 9.9 8.2 7.3
OECD 8.5 11.3 10.8 9.5 9.7 8.7
Canada 13.5 15.8 18.7
Italy 7.9 9.4 10.3
OECD 6.4 9.6 13.7 15.9
Infant mortality, Deaths per 1 000 live births
Life expectancy, Total population at birth, Years
Intentional self-harm, Deaths per 100 000 population 
Tobacco consumption, % of population 15+ who are daily smokers
Alcohol consumption, Liters per capita (age 15+)
Obese population, self-reported, % of total population








in 2007 and has since remained above.   Between the 1960s and the 2010s, average annual life 
expectancy at birth in Canada rose from 71.7 to 81.7 years, while in Italy it rose from 69.8 to 
82.7 years.  Of additional interest, suicide rates (intentional self-harm) in both Canada and Italy 
are below the OECD average, and both have declined since the mid-1980s with suicide rates in 
Italy dramatically lower than in Canada.  
We use aggregated social expenditure data from the OECD.29  As a share of GDP, social 
expenditure has risen over time in both Italy and Canada, but Italy generally spends more (See 
Figure 2).  For example, in 1980 Canada spent 13.3 percent of GDP on social programs, 
compared to 17.4 percent for Italy.  Over the last approximately 40 years, that percentage has 
grown to 28.1 percent in Italy in 2017 and ultimately reached 17.3 percent in Canada after 
declining from a  peak of 18.4 percent in 1995 in the wake of the intergovernmental transfer 
cuts of the federal fiscal crisis.   
Figure 2: Social Expenditure as a Percent Share of GDP 
 
Source:   OECD Stat. https://stats.oecd.org/Index.aspx?datasetcode=SOCX_AGG 
 
29 OECD Stat. https://stats.oecd.org/Index.aspx?datasetcode=SOCX_AGG 







There are differences in social expenditure focus in the two systems.  Public expenditures on 
old age and survivors cash benefits are higher in Italy, reflecting a more generous Italian social 
security system. In 1980 Canada spent 3.1 percent of its GDP on old-age related transfers, and 
this grew to 4.7 percent in 2015. In Italy it already reached 8.6 percent in 1980, and by 2015 it 
almost doubled to 16.2 percent. By comparison, the OECD average spending on old-age related 
transfers was 5.5 percent of GDP in 1980 and 7.5 percent in 2015. 
Public expenditures on disability and sickness cash benefits are nearly double in Italy 
compared to Canada, at 0.8 percent of GDP in Canada and 1.7 percent in Italy in 2015.  Direct 
public expenditures on family (in cash and in kind) were 1.5 percent of GDP in Canada, and 2 
percent of GDP in Italy in 2015.   Telling of the extent of the redistribution of income through 
social programs is the income of older people aged 65 and over, as a percent of the general 
population income.  In 2014 those 65 years and older in Canada had 91.1 percent of the income 
of the general population, as compared with 98.8 for Italy, while the OECD average was 87.6 
percent. 
Figure 3: Top 1% Percent Share of Adult Pre-Tax Income 
 
Source: World Inequality database   https://wid.world/ 








With respect to income inequality, OECD Gini coefficients30 for Canada and Italy show that in 
2016 Italy was slightly more unequal than Canada with a Gini of 0.33, compared to 0.31 for 
Canada.  However, measuring inequality as the pre-tax income share of the top 1% of adult 
earners, Canada appears to have greater income inequality than Italy.   The income inequality 
data for Italy should be treated cautiously, since it has a relatively large shadow economy,31 
making officially reported market income to construct inequality measures potentially 
unreliable. 
Figure 3 plots the pre-tax income share of the top 1 % of adult earners for Canada and Italy 
using data from the World Inequality Database.32  The top 1 percent of earners was used as the 
inequality measure given that more preferable Gini coefficient data  was not available. While 
income inequality as measured by the top 1 percent of earners has grown in both countries over 
time, Canada has greater income inequality than Italy, at least before taxes and transfers are 
factored in. As noted, the relatively large size of the black-market economy in Italy compared 
to Canada means that these data may understate the extent of regional or individual level 
inequality. 
To summarize, Canada spends more than Italy on health care, but Italy has surpassed 
Canada in basic health indicators like longevity and infant mortality.  Despite spending more 
on health both per capita and relative to GDP, Canada per capita has fewer physicians, fewer 
hospital beds and less medical technology, but does have more nurses and physician 
consultations. Despite spending more, based on the basic health indicators of longevity and 
infant mortality Canada appears to be getting less.  
4    Methodology 
We conduct regression analysis on health care spending drivers and key health indicators to 
determine the responsiveness of health spending and health indicators to common determinants 
for Canada and Italy.  Along with using the results to examine the determinants of health 
spending, the regression results are also used to conduct a counterfactual simulation. 
4.1    Regression Analysis 
There is an extensive literature on the determinants of health spending – both public and private 
– with key expenditure drivers including population growth, physician numbers given the gate 
keeping role of physicians,33 population aging, income, inflation, and enrichment factors such 
 
30 https://data.oecd.org/inequality/income-inequality.htm 
31 See Medina and Schneider, 2018 for a discussion.   
32 https://wid.world/ 
33 For a discussion see Di Matteo (2014). 







as technological change as often by diagnostic equipment usage or by time trend. These studies 
have been carried out at the national, international and regional levels.34   
Even though Canada and Italy are very regionalized countries, we focus on national level 
determinants of health expenditures for several compelling reasons.  First, while Canadian 
health care is delivered by the provinces with regional differences in per capita spending and 
services, health outcomes are consistently high across the country.  Italy also has consistency 
in health outcomes across its regions, though there are regional differences in spending 
(Francese and Romanelli 2011)35.  Second, the lack of available regional level data across a 
long enough time span for both spending, service provision and health outcomes make it 
impossible for our study to focus on regions.  While sufficient and comparable time series going 
back to 1970 are either available or can be constructed at the national level, the data issue 
becomes more problematic at the region/province level. For Canada, provincial level health 
expenditure data is available going back to the mid-1970s from the National Health Expenditure 
Database of the Canadian Institute for Health Information.  For Italy, the data sets for regional 
spending only go back to the 1990s. 
Third, a high-level national comparison is better given institutional differences in the roles 
of regions/provinces in health care across Canada and Italy. Canadian provinces have 
considerably more autonomy in the areas of health and education spending than do Italian 
regions.  Canada is a decentralized federation where the provinces deliver and fund health care, 
whereas in Italy, regional health care provision is accompanied by much more centralization 
with respect to funding and provision.  Thus, our decision to rely on national level data. 
We model the determinants of health expenditure in Canada and Italy as:  
 
Ht = f(z1t, z2t, ….znt)                                             (1) 
where Ht is real per capita government health expenditures and z1 to zn represent a vector of 
social, demographic, economic and policy variables at time t which are determinants of Ht.36  
 
34 See Constant et al., (2011).  For an excellent survey of the international health expenditure determinants 
literature, see Gerdtham and Jonsson (2000).  The first generation of such determinants studies often 
used international data.  See Leu (1986), Parkin et. al., (1987), and Gerdtham et al (1992). See also 
Hitiris and Posnett (1992), Barros (1998), Gerdtham et. al, (1998), Di Matteo and Di Matteo (1998), 
Ariste and Carr (2003) and Crivelli, Filippini and Mosca (2006). For some more recent papers, see 
Cantarero Prieto and Lago Penas (2010), Magazinno and Mele (2012), Di Matteo (2010, 2014), Di 
Matteo and Emery (2014), Braendle and Columbier (2016), Nghiem and Connelly (2017), Yetim et al, 
(2020). 
35 Generally, the southern part of Italy has lower per capita healthcare spending. The regional differences 
in healthcare spending is partly offset by southern Italians travelling north for health care services. 
36 The variables are: PPP GDP Per Capita Current Prices; Population (millions); Unemployment Rate 
(%); Total Health Exp to GDP (%) HGDP; Per Capita Total Health Expenditure USPPP$;  Public 
 








The national level data for these regressions covers the period 1970 to 2017, and comes from 
OECD Health Statistics 201837, supplemented by data from the World Bank, the OECD Social 
Health Expenditure Database38, the IMF WEO Database39, the World Inequality Database,40  
and FRED.41  The specification is log-linear, and the estimation technique is Robust Regression 
which helps address the potential impact of outliers in data.42  We  conducted Augmented 
Dickey-Fuller tests on the regression variables and found a high degree of stationarity across 
the variables in the dataset.43 
Table 4 reports our results for per capita public and per capita total health expenditures.  The 
final reported specifications regress the health expenditure variables on GDP per capita in U.S. 
PPP dollars lagged one year44 (a measure of long term income impact), the first difference of 
GDP per capita in U.S. PPP dollars (a measure of short term income fluctuations), physicians 
per 1,000 population, nurses per 1,000 population, the number of MRI machines per one million 
population (a variable to represent the impact of diagnostic technology on health spending), 
and the percent of population aged 65 years and over using a quadratic specification to reflect 
the fact that while aging populations can drive up health spending, eventually steps will be 
taken to restrain it making for a hump shape. 
We find differences driving per capita health spending across the two countries. Lagged per 
capita GDP is a significant long-term driver of per capita Canadian health spending, but short-
term fluctuations in GDP are not, with opposite response to these two variables for Italy. It is 
unclear why per capita health spending is less responsive to the level of GDP in Italy compared 
to Canada, but given the significance of the first difference of GDP per capita for Italy (but not 
 
 
Health Exp Per Capita USPPP$; Infant Mortality Deaths per 1000 live births; Life Expectancy at Birth 
Years; Self Harm (Suicides) Deaths per 1000; Alcohol Consumption Litres Per Capita; Tobacco 
Consumption.  % pop 15+ who smoke; Physicians per 1000 Population; Medical Graduates Per 1000 
Population; Nurses per 1000 population; Total Hospital Beds per 1000 population; MRIs per one 
million people; CTs per one million people; Doctor consultations Per Capita; Percent of population 
Aged 65 Years and Over; Social Expenditure Share of GDP (%); Social Expenditure Per Capita 





41 FRED is the Federal Reserve Bank of St. Louis Database. See: https://fred.stlouisfed.org/ 
42 It should be noted that while the data for these regressions is from 1970 to 2017, some of the variables 
did not have complete coverage and as a result gaps were filled using a regression that regressed the 
available data on time trend and the coefficients used to fit the data to the missing years. 
43 The ADF test was done employing no constant or trend and two lags.  For most of the variables, the 
hypothesis of a unit root was rejected at the 5% and 10% level and occasionally at the 1% level. 
44 Initial specifications also included 2- and 3-year lags, but they were found to be of low impact.  







Table 4: Health Expenditure Determinant Regression Results 
Dependent Variable: Log of Per Capita Total Health Expenditure USPPP$ 
 
Canada Italy 
Coefficient t-statistic Coefficient t-statistic 
GDP Per Capita in PPP Dollars Lagged One Year 0.000039 4.06 0.000004 0.33 
First Difference of GDP Per Capita in PPP Dollars 0.000004 0.24 0.000039 1.91 
Physicians per 1000 Populatoin 0.498666 3.83 0.648925 2.32 
Nurses per 1000 Population 0.002573 0.10 1.187990 9.88 
MRI per Million Population -0.033041 -1.9 0.010492 1.25 
Percent of Population Aged 65 Years and Over 0.749569 7.23 -0.014850 -3.81 
Percent of Population Aged 65 Years and Over Squared -0.026910 -8.42 -0.014850 -1.89 
Constant 0.607742 1.00 0.903599 0.81 
R-squared 0.9028  0.7639  
F-Statistic (7,39) 1349.63  854.35  
Dependent Variable: Log of Public Health Expenditure Per Capita USPPP$ 
GDP Per Capita in PPP Dollars Lagged One Year 0.000043 3.72 0.000014 0.77
First Difference of GDP Per Capita in PPP Dollars 0.000001 0.08 0.000077 2.43 
Physicians per 1000 Populatoin 0.692374 4.44 0.545579 1.27
Nurses per 1000 Population 0.000212 0.01 1.110165 6.00 
MRI per Million Population -0.042219 -2.03 0.021116 1.64 
Percent of Population Aged 65 Years and Over 0.626672 5.05 0.249538 1.31
Percent of Population Aged 65 Years and Over Squared -0.023560 -6.16 -0.016379 -2.73 
Constant 0.808397 1.12 1.137162 0.67
Adjusted R-squared 0.8962 0.8270 
F-Statistic (7,39) 869.39 321.66 
Bold denotes significant at 5 percent level; Bold italics is significance at 10 percent level 
for Canada) it may be that there is more sensitivity in Italian health expenditures to changing 
economic circumstances. Italian health spending is more centralized than Canada which means 
that changes resulting from resource fluctuations can be transmitted more rapidly across the 
system.45  
 
45 GDP per capita has gone up a bit more in Canada compared to Italy since 1990.  In 1990 GDP per 
capita in Italy was US$18.55K and in Canada US$20.25k. In 2016 it was 44.92k in Canada and 39.04 
in Italy: https://data.oecd.org/gdp/gross-domestic-product-gdp.htm. It should be noted that the data is 
PPP at current prices. 








With respect to the impact of GDP on health spending, it is important to note Italy’s shadow 
economy is generally held to be larger than Canada’s.  According to a study by the University 
of Tubingen in West Germany (IAW), as a percentage of GDP Italy’s shadow economy was 
almost 20 percent (19.8%), while Canada’s shadow economy in 2017 is estimated at 9.8 
percent.46 The relatively large shadow economy in Italy probably understate  levels of GDP and 
GDP per capita. It should also be emphasized, that if GDP and GDP per capita are understated 
it could make the Italian health care system look more efficient, since it implies that Italy spends 
a lower percentage of its GDP on health care. 
Physician numbers are positive drivers of spending in both Canada and Italy and the 
coefficient estimates suggest the response is weaker for Canada when it comes to total health 
spending, but greater for public health spending. We note that the larger coefficient on 
physician numbers in Canada as a determinant of public health spending  relative to Italy may 
be due to family physicians being paid on a capitation basis in Italy, whereas in Canada the fee-
for-service approach still dominates.  It is also possibly a function of physicians paid relatively 
more in Canada than Italy.  In 2015 Canadian specialist physicians average gross income was 
4.5 times more than the average wage while in Italy the ratio was 2.5.47 As another example, in 
2011, specialist physicians in Canada in US$ PPP received annual remuneration of $213,000 
while in Italy it was $93,000.48 The lower remuneration for Italian physicians partly enables a 
relatively larger number of medical  doctors per 1000 inhabitants: In 2018 Italy had 3.9 doctors 
while Canada had 2.5.49  The number of doctors grew very rapidly in the 1970s and 1980s 
(Walton and Binns, 1984) in Italy, which put downward pressure on doctors’ salaries. The rapid 
rise in the number of doctors in Italy in the 1970s and 1980s is attributable to the elimination 
of entry barriers in medical schools in the late 1960s.50 Students wishing to study medicine 
could enroll in the faculty of medicine of any Italian university.   
 However, the same explanation does not appear to hold for nurses.  Nurses per 1,000 
population is not a significant driver of Canadian health spending at either the total or public 
 
46 Reported in Forbes, February 9, 2017, https://www.forbes.com/sites/niallmccarthy/2017/02/09/where-
the-worlds-shadow-economies-are-firmly-established-infographic/#7459be0c742c 
47 Source: OECD (2017), “Remuneration of doctors (general practitioners and specialists)”, in Health at 
a Glance 2017: OECD Indicators, OECD Publishing, Paris. 
48 Remuneration of Doctors and Nurses: Progress and Persisting Issues. Joint Sessions of Health Data 
correspondents and Health Accounts Experts. Paris, 17 October 2013. OECD. 
https://www.oecd.org/els/health-systems/Item6_Remuneration-of-doctors-and-nurses_Durand.pdf. 
49 Italy has one of the highest numbers of medical doctors in the OECD. There are historical reasons for 
this. In the late 1960s access to medical schools was made available to anyone that wanted to register 
for them and led to an explosion of graduates. See Walton and Binns (1984). For many years in the 
1980s and 1990s there were many unemployed medical doctors in Italy, which ultimately had an impact 
on doctors’ salaries.  
50 Thorne (1996). 







level but is for Italy.  This is an intriguing result given Italy has more physicians but fewer 
nurses per capita than Canada, and Canadian nurses are paid substantially more than Italian 
nurses.   Again, according to the OECD the remuneration of hospital nurses in US$PPP in 2011 
was $51,000 in Canada and $37,000 in Italy.51  This suggests that it is not numbers or costs 
alone, but perhaps differences in use and role of nurses in the health care process.   
New diagnostic technology has a differential impact on spending across the two countries.  
For Canada, increasing the number of MRI units is associated with a decrease in per capita 
health spending at both the total and public level.  For Italy, the result has been positive, though 
only significant for public health care spending and at the 10% level.  Again, this suggests a 
potentially differential effect across Italy and Canada over time on per capita health spending 
from the introduction of new diagnostic technologies. Technological change can have cost-
enriching effects if increased demand results from new procedures. Even if the new techniques 
generate less expensive health procedures, the ultimate impact on spending will depend on the 
interplay of the two forces.52   
Finally, an aging population is a positive driver of health spending in both countries, but 
based on the coefficient sizes, the magnitude of the effect is greater in Canada.  In both 
countries, the relationship between proportion of population aged 65 and over is a quadratic 
(hump-shaped).   With respect to total per capita health spending, an aging population has its 
peak positive effect on health spending in Canada until the percent aged 65-and-over reaches 
14 percent of the population, and for Italy when that percentage reaches 8 percent.  This 
suggests that Italy may have moved earlier to deal with the costs of an aging population. 
However, it could also be a “statistical illusion” in that the over-65 population in Italy began to 
grow at an earlier period compared to Canada. 
The efficacy of both health and social spending on life expectancy (LE) and infant mortality 
is considered in the regressions in Table 5.  The log of life expectancy at birth and the log of 
infant mortality rates are regressed on the following key variables: lagged level of per capita 
GDP in U.S. PPP dollars, alcohol consumption per capita (litres), tobacco consumption53, 
 
 
51 Source: Remuneration of Doctors and Nurses: Progress and Persisting Issues. Joint Sessions of Health Data 
correspondents and Health Accounts Experts. Paris, 17 October 2013. OECD. 
https://www.oecd.org/els/health-systems/Item6_Remuneration-of-doctors-and-nurses_Durand.pdf. 
52 For example, Cutler et al. (1998) report that the real quality-adjusted price of heartattack treatments 
declined at an annual rate of 1.1 percent between 1983 and 1994. 
53 It should be noted that alcohol consumption between males and females on an annual basis for the period 
under review was not available. As for tobacco consumption, while separate data series for males and females 
were available, both have trended down over time and since second-hand smoke can be just as dangerous as 
first-hand smoke, we opted to use the aggregate data.  








Table 5: Health Status Indicators Determinants Regression Results 
Dependent Variable: Log of Life Expectancy at Birth in Years 
 
Canada Italy 
Coefficient t-statistic Coefficient t-statistic 
GDP Per Capita in PPP Dollars Lagged One Year 0.000002 9.81 0.000003 6.80 
Alcohol Consumption (Litres per capita) -0.002733 -5.35 -0.000003 0.00 
Tobacco Consumption (%15 years plus who smoke) -0.000538 -1.64 -0.003852 -4.62 
First Difference of Per Capita total Health Expenditure in PPP 
Dollars 
0.000006 0.56 0.000000 0.03 
First Difference of Social Expenditure Per Capita in PPP 
Dollars 
-0.000002 -0.48 -0.000004 -0.49 
Total 1% Income Share -0.001271 -2.43 0.000151 0.10 
Constant 4.353289 325.94 4.404139 139.96 
R-squared 0.853000 0.875700 
F-Statistic (6,40) 1238.18 764.73 
Dependent Variable: Log of Infant Mortality (Deaths per 1000 Live Births) 
GDP Per Capita in PPP Dollars Lagged One Year -0.000016 -1.83 -0.000048 -8.15 
Alcohol Consumption (Litres per capita) 0.137729 7.01 0.027815 2.59 
Tobacco Consumption (%15 years plus who smoke) 0.013981 1.11 0.012768 0.97 
First Difference of Per Capita total Health Expenditure in PPP 
Dollars 
-0.000633 -1.60 -0.000047 -0.20 
First Difference of Social Expenditure Per Capita in PPP 
Dollars 
0.000015 0.08 -0.000102 -0.78 
Total 1% Income Share 0.051073 2.54 -0.018311 -0.81 
Constant 0.241695 0.47 2.454694 4.94 
R-squared 0.8109 0.8654 
F-Statistic (6,40) 100.02 769.09 
Bold denotes significant at 5 percent level; Bold italics is significance at 10 percent level 
defined as the percent of population aged 15 years and over who smoke, the first difference of 
per capita total health expenditure in U.S. PPP$, the first difference of social expenditures per 
capita in U.S. PPP$ 54 and the income share of the top 1 percent.   We use per capita GDP rather 
than changes in GDP as the determinant of changes in health status given its standard use in the 
 
54 Initial data exploration using LOWESS found that the relationship between life expectancy and the per capita 
health spending variable or its first difference was increasing.  Similarly, the LOWESS plot between infant 
and per capita health spending or its first difference was a decreasing relationship.  As a result, quadratic 
specifications were not employed. 







literature.55 With respect to public spending, changes at the margin are more immediate input 
factors affecting current health status – therefore, the use of first differences in health and social 
expenditure.56  As in our first set of regressions, Robust regression estimates were done. 
Table 5 suggests that for both countries, the level of per capita GDP is a key determinant of 
increased life expectancy and falling infant mortality for Italy, but not for Canada.  Tobacco 
consumption significantly reduces life expectancy in both countries (but at the 10 percent level 
for Canada), while alcohol is correlated with reduced life expectancy in Canada but not Italy.  
Alcohol consumption significantly increases infant mortality in Italy and Canada, while tobacco 
consumption increases infant mortality in Canada and Italy but is not statistically significant in 
either country.  The health effects of tobacco consumption during pregnancy have been widely 
known for decades, and the reductions in consumption rates in both countries over time may be 
a factor in the insignificance of the results with respect to infant mortality. 
The effect of marginal changes in total health spending on health outcomes are insignificant 
drivers of life expectancy and infant mortality in both countries.  Moreover, when it comes to 
social spending, changes in expenditures at the margin are also insignificant contributors to life 
expectancy and infant mortality.  Given the high level of social and economic development of 
Canada and Italy, it is not surprising that changes in health and social spending at the margin 
are not significant determinants of health status.  Instead, the key drivers appear to be the long-
term level of economic development as captured by levels and changes in income, with some 
influence of tobacco and alcohol use. 
As for income distribution and inequality, we find that an increase in the income share of 
the top 1% in Canada is statistically significant in decreasing life expectancy and increasing 
infant mortality.  For Italy, an increase in income inequality is not a statistically significant 
determinant of either life expectancy or infant mortality.   While it may be that the effects of 
income inequality on health outcomes may be weaker in some developed countries with good 
public health systems, the Canadian results may be driven by the poorer health outcomes among 
its indigenous peoples.57   
Another possibility driving Italian results is the large proportion of social transfers devoted 
to income redistribution, especially for the elderly, which may serve to weaken the effect of 
market income inequality on life expectancy.  We  have already noted  that in Italy  market 
incomes do not reflect the broader underground economy, which implies  that official income 
figures used also to estimate inequality do not reflect the true extent of either individual or 
regional inequality in Italy. 
 
55 The health determinants literature focuses on level of income as a key determinant of health spending. 
56 The levels of these two expenditure variables are also highly correlated with GDP. 
57 For discussion, see Ring and Brown (2003) and Smylie and Firestone (2016). It should be noted that it 
would have been superior to use the Gini coefficients in both countries, but consistent annual data is not 
available.  








Our results tell a consistent story of the determinants of health outcomes.  The key 
determinants in both countries are more closely tied to income, as well as lifestyle choices such 
as drinking and smoking, rather than interventionist medical care or social spending.  If 
inequality is considered a social determinant, then it matters more for Canada than Italy.  The 
results partly buttress the case for the broader determinants of health status, with socio-
economic factors such as lifestyle choices, per capita income and income distribution as more 
significant determinants of health outcomes than interventionist health and social spending.58 
A key result is that medical and social spending alone do not explain health outcomes.   
Changes in per capita health spending in both Italy and Canada are not significant determinants 
of either life expectancy or infant mortality.  The implication is that over the long-term, per 
capita income and lifestyle choices (such as tobacco and alcohol consumption) are more 
important to health outcomes than actual direct expenditures on health services.  Yet, social 
spending is also not a significant determinant of either life expectancy or infant mortality, 
though income inequality has some effect on health status.   
4.2    Counterfactual Simulation 
As an additional exercise, the regression coefficients in Table 4 for the determinants of the log 
of total health expenditures are used to perform a counterfactual simulation that asks the 
following question: Given the actual national performance of Italian GDP, GDP growth, health 
human resources, technology use and age structure over the period 1970 to 2016, what would 
per capita total health spending look like if the same data was combined with the regression 
coefficients from Canada’s total health expenditure regression to construct an alternative fitted 
value that could then be compared to the original Italian ones?  Similarly, such an alternative 
health expenditure estimate is also computed for Canada using its own data values but the 
Italian regression coefficients.  
The results are presented in Appendix 1.  For both countries, as expected, their actual and 
fitted results move quite closely together, suggesting the estimated models do a good job of 
explaining their real per capita total health spending.  What is also interesting is the result when 
their own numbers are plugged into the other country’s regression.   
For Canada, the Italian coefficients generate rising counterfactual health spending over time 
that tracks its actual spending, but usually at a lower level and with some interesting larger 
divergences – the early 1980s and much of the 1990s plus a period in the early 2000s.  These 
periods of decline in counterfactual health spending occurred during times of recession or slow 
economic growth.  The Italian coefficients make Canadian health spending more sensitive to 
changes in GDP.  
 
58 For an overview of the social determinants of health, see Braveman, Egerter and Williams (2010). 







Substituting Italy’s numbers into Canada’s regression generates a large surge in per capita 
Italian spending relative to actual expenditures over the period 1970 to approximately the mid 
-1990s.   This result suggests that up until the 1990s, the Canadian health system was more 
costly compared to the Italian health system.   Given the same economic and demographic 
inputs, Canada spent more.  However, the 1990s were a tumultuous time in Canadian public 
spending and health spending since the federal fiscal crisis generated major changes in 
Canadian intergovernmental transfers that ultimately placed health care spending on a lower 
growth trajectory compared to the period prior to 1990.   In the Italian case, when combined 
with its weaker overall economic growth performance over the period since the late 1990s – it 
generates a sustained decline in per capita health spending.  Indeed, annual real GDP growth in 
Italy from 1995 to 2017 averaged barely 1 percent while in Canada it was just over 2 percent.  
5    Discussion 
It is not possible to definitively conclude from our results that one system is “more efficient” 
than the other given the differences in the economies, societies and health system structures of 
Canada and Italy. We need to acknowledge the challenges associated with measuring and 
comparing the value for money or cost-effectiveness of these two-health care system.  For 
example, we chose to emphasize infant mortality and the length of life as an indicator of the 
“output” of the healthcare system, but more difficult to measure and ascertain is the quality of 
extra years of life.  
With respect to income as a health spending driver, it is a significant long-term driver of per 
capita Canadian health spending, but short-term fluctuations in GDP are not, as opposed to Italy 
which seems to exhibit an opposite response to these variables. Our results suggest the Canadian 
health system has more long-term structural inertia with respect to resource use, while Italian 
health spending is more responsive to short term income fluctuations.  The difference in 
response may be the result of institutional differences given that Canadian health care provision 
is quite decentralized compared the Italian health care system.  
Physician numbers have similar positive effects on health spending in Canada and Italy, but 
the number of nurses is more important for Italy.  These results point to the similar role of 
physicians as gatekeepers to the system in both countries. But in the Italian case, given that 
there are more physicians, the public health system may have had more incentive to restrain 
physician expenditure through the remuneration system. With respect to the impact of nursing 
numbers, the difference may be due to differences in aspects of health care provision such as 
the reliance on family to provide some of the hospital-based care in Italy – most likely an 
important factor given the relatively low number of nurses in Italy compared to Canada.   
Adding nurses substitutes positive amounts of spending for what essentially is being provided 








for free by family members. Moreover, given the relatively lower number of nurses in Italy, if 
more nurses were added, it would operate to increase health expenditures at the margin. We 
have already noted that the lower salaries of both medical doctors and nurses is a contributing 
cost factor in the lower spending of the Italian health care system. 
For Canada, increasing units of diagnostic technology per capita is associated with a 
decrease in per capita health spending at both the total and public level.  For Italy, the result is 
positive, though only significant at the 10% level for public health care spending.   It could be 
that the early diffusion of diagnostic technology helped reduce health care costs via more 
accurate and earlier diagnosis, and Canada has lagged Italy in the diffusion of this technology.  
However, over time increases in the technology may contribute more to costs than to benefits 
as more anomalous findings – or incidentalomas are generated – which merit further and 
costlier follow up.59 The role of diagnostic imaging in affecting health costs is an area of some 
debate in the health economics literature and the results here do not resolve this debate.60 
While Italy has a higher proportion of population aged 65 years and over, aging is a more 
significant driver of health spending in Canada.  By 2017, the proportion of population aged 65 
years and over was 17 percent in Canada and 23 percent in Italy. The results for Italy could be 
due to the percentage of the population over 65 began growing at an earlier point in time, 
sparking more advanced health sector cost control measures.  Or, it could reflect an institutional 
difference whereby more of the health needs of the elderly are met outside the health care 
system in Italy compared to Canada. For example, the result of families and private personal 
care workers providing care.    
In Italy health costs have been restrained in the elderly population through the wide-spread 
hiring of foreign in-home elder care workers (the badante)61.  The Italian government provides 
families with cash supplements to hire in-home elder care workers.  Thus, what appears at first 
to be cost reducing measures in providing for the elderly, is in fact a bit of a mirage; resources 
spent for elderly care come from the social expenditure category.  
Ultimately, Canada spends a larger share of its GDP and greater amounts per capita on 
health than Italy while Italy has somewhat better outcomes.  Given Canada’s higher per capita 
GDP relative to Italy, all this may simply mean is that Canada is willing and able to spend more 
on health.  However, this is not a satisfactory explanation given that while it may explain 
differences between the Canadian and U.S. health systems – which are quite different – it 
 
59 Wagner and Aron (2012). 
60 For some literature in this area, see Beinfeld and Gazelle (2005), Sullivan (2014) and Marchildon and 
Di Matteo (2011).   
61 See Gori, 2012 







remains that both Canada and Italy have largely public single payer systems with many 
similarities.62 
One possibility is that there may indeed be differences in health outcomes due to lifestyle 
choices making it possible for the Italian system to spend less relative to Canada and yet achieve 
better outcomes.  Indeed, the regression results for Italy and Canada show that over the long-
term, lifestyle choices may be more important to health outcomes than actual direct 
expenditures on health services.   Another possibility is that there may be something about the 
role and structure of health care that differs across the two countries. To examine this 
hypothesis, we employed a counterfactual to determine whether health spending in Italy and 
Canada would be different if the relationship driving health spending was that of the other 
country. The results suggest that something about the structure of the determinants of Canadian 
health spending resulted in more spending, all other things given. 
Higher present Canadian health spending levels relative to Italy are a function of historical 
inertia combined with stronger economic growth. Going back to the 1970s, the level of health 
spending in Canada was higher compared   to Italy.  At the same time, since the 1970s, Italy 
has shown greater improvements in mortality and life expectancy than Canada.  Italy does spend 
less per capita for equivalent or better outcomes but this may not necessarily mean that Italy 
has been able to get greater value for money per additional health dollar spent because it is 
based on levels of spending rather than the responsiveness of outcomes to changes in spending 
which is what a measure of cost effectiveness should do. 
Canadian total per capita health spending from 1970 to 2017 in US$ PPP grew from $289 
to $4826 – an increase of 1,570 percent. Meanwhile, infant mortality declined 77 percent and 
life expectancy at birth rose 14 percent.  Over the same period, Italian health spending in US$ 
PPP rose from $172 to $3,541 – an increase of 1,959 percent. However, infant mortality fell 90 
percent and life expectancy at birth grew 17 percent.  From these numbers, the elasticity of 
infant mortality decline with respect health spending is -0.049 for Canada and -0.046 for Italy.  
The elasticity of life expectancy at birth to per capita health spending is 0.009 for Canada and 
0.009 for Italy.  When examined in additional dollars spent at the margin, outcomes in Canada 
and Italy are the same.  However, Canada achieves these results with a higher level of spending 
per capita, which is shaped by higher costs, particularly with respect to health professional 
compensation.   
 
62 In the case of Canada and the United States, the U.S. far outspends Canada on health care with poorer 
outcomes with respect to health indicators.  Much of the difference in spending was due to Canadians 
spending less on physicians and hospitals relative to the United States, higher administrative costs in 
the United States and higher incomes in the U.S. and more intensive provision of medical procedures. 
Pozen and Cutler (2010). 








6    Conclusion 
The greater levels of per capita health spending in Canada relative to Italy are largely a function 
of initial conditions rooted in Canada’s higher economic output and historically higher salaries 
for medical professionals.  Our results also suggest that the most important determinants of 
health outcomes in both Canada and Italy appear to be per capita income and to a lesser extent, 
lifestyle variables, such as alcohol and tobacco consumption.  
Our results give credence to Anderson et. al. (2000), Golinelli et.al (2018), and Cremieux 
et.al (1999) that health expenditures have some positive impact on health outcomes, but that 
complex lifestyle forces also matter.  It may also be that once health spending has reached a 
certain level in high income countries, diminishing returns set in and additional spending 
increments contribute little health indicators such as life expectancy or infant mortality.   
As for the role of social spending being more important than health spending, our results 
suggest social spending is not a significant driver of health outcomes in Canada or Italy – which 
spends a larger share of its GDP on social expenditures relative to Canada with much of the 
difference accounted for by the more generous public pension system in Italy.  Rubin et. al. 
(2016) show that old-age spending appears to make a significant contribution to better health 
outcomes but suggest that social spending and protection may be more important to better 
health outcomes in societies in which income inequality is high. Lynch et. al. (2004) also argue 
that reducing inequality of the most disadvantaged population can improve health outcomes.  
Neither Italy nor Canada have very high-income inequality, which may explain why social 
spending is not the main determinant of health outcomes in either country.  Moreover, generous 
Italian pensions for the elderly started soon after 1945, which may explain why higher social 
spending in Italy did not impact our results.  
Our results reinforce Latif (2015): income inequality is not nearly as important to health 
outcomes compared to the level of absolute income.  Canada does spend more on health care 
relative to Italy, but based on the responsiveness of basic indicators to increase in health 
spending over time, each additional dollar spent on health in Canada and Italy appears to have 
yielded the same increments in life expectancy increases and infant mortality declines in the 
period since 1970.  Canada and Italy therefore are equivalent in terms of the cost effectiveness 
of additional dollars spent on health as measured by our outcomes.   
Canada spends more on health care for historical and institutional reasons with higher 
remuneration for physicians and nurses a contributing factor. For nurses, Canada has more of 
them per capita while Italy has fewer and their salaries are less than nurse incomes in Canada. 
Canadian doctors are paid much more than Italian doctors. The higher income for Canadian 
doctors is at least partly attributable to the fee-for-service model, compared to the capitation 







model in Italy. This suggests that Canada’s seeming tendency to spend more and get less is a 
result of historical long-term spending patterns and factors which have had a long-term 
structural impact on the efficiency of the Canadian health care system. 
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Appendix 1: Counterfactual Simulation 
Figure A1.1: Canada: Counterfactual Simulations (Log of Per Capita Total health 
Expenditure) 
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